Background: Coagulopathy associated with COVID-19 infection and venous
thromboembolism (VTE) have emerged as significant contributors to morbidity among …

Background: Recent studies revealed a high prevalence of venous thromboembolism (VTE)
events in coronavirus disease 2019 (COVID-19) patients, especially in those who are …

Background: Emerging evidence shows that coronavirus disease 2019 (COVID-19) is
commonly complicated by coagulopathy, and venous thromboembolism (VTE) is considered …

Severe coronavirus disease 2019 (COVID-19) is associated with increased risk of venous
thromboembolism events (VTE). This study performed a systematic review in …

Introduction: Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection resulting in COVID-19 disease is associated with widespread inflammation and a …

Introduction Venous thromboembolism (VTE) has been observed as a frequent complication
in patients with severe novel coronavirus disease 2019 (COVID-19) infection requiring …

Background: Accumulating evidence suggests that coronavirus disease 2019 (COVID-19) is
associated with hypercoagulative status, particularly for critically ill patients in the intensive …

Background: Preliminary evidence indicates that prophylactic-dose thromboprophylaxis may
be inadequate to control the increased risk of venous thromboembolism (VTE) in patients …

Background: Coagulation disorders are frequently encountered among patients infected
with coronavirus disease 2019 (COVID-19), especially among admitted patients with more …

Patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
appear to be at increased risk for venous thromboembolism (VTE), especially if they become …